GlassScriptPhysician profile
Mansi Parikh
NPI 1417434853
$6,477.55
in general payments reported to CMS, 2019-2025
17 companies · $3,514 in 2025
The $3,514 reported for 2025 was more than what 98% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $475 · 2020: $289 · 2021: $61.55 · 2022: $922 · 2023: $30.29 · 2024: $1,185 · 2025: $3,514.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,313 · Food and Beverage: $1,417.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,312.50 |
| Food and Beverage | $1,417.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optos, INC. | $3,312.50 | 2025 | |
| Lumenis Be INC | $623.56 | 2024 | Optilight |
| Bausch & Lomb Americas INC. | $467.47 | 2022-2025 | Xiidra, Miebo |
| Johnson & Johnson Vision Care, INC. | $425.94 | 2019-2022 | |
| Alcon Vision LLC | $382.44 | 2019-2024 | Precision 1, Total30 |
| Coopervision INC. | $190.14 | 2020-2025 | Clariti Contact Lens, Myday Contact Lens |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $166.46 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $143.11 | 2020-2025 | Eylea Hd |
| Sight Sciences, INC. | $131.25 | 2022 | |
| Glaukos Corporation | $126.71 | 2022 | |
| Dompe US, INC. | $125.74 | 2024 | Oxervate |
| Harrow Eye, LLC | $125.00 | 2024 | Vevye |
| Eyevance Pharmaceuticals LLC | $90.94 | 2022 | |
| Rxsight INC | $76.26 | 2024 | Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens, Light Adjustable Lens (Lal) |
| Allergan, INC. | $69.42 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tarsus Pharmaceuticals, INC. | $20.61 | 2024 | Xdemvy |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mansi Parikh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.